Now, Moderna says it has given doses to the first participants in a clinical trial looking at an influenza vaccine using mRNA technology. Before the pandemic, mRNA technology was known about but was widely unexplored and unused by scientists. The flu shot under development targets four strains of flu recommended by the World Health Organization (WHO): A (H1N1), A(H3N2), B/Yamagata and B/Victoria. It is also the second most commonly used vaccine in the U.S. - only trailing the Pfizer-BioNTech vaccine - having been administered over 135 million doses. Including the flu shot, Moderna is trialing 14 different mRNA vaccines in the near future, as they are optimistic about the technology's ability to prevent all types of disease.

Source: Daily Mail July 08, 2021 16:41 UTC